Treating RSD with MMJ-A Second Look in Year Two of Treatment

Showing posts with label Former pharmeceutical representative speaks out. Show all posts
Showing posts with label Former pharmeceutical representative speaks out. Show all posts

Wednesday, October 16, 2013

Ex-Pharmaceutical Rep. Speaks Out

Posted by A. Johnson at 6:18 AM No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Labels: adverse reactions to psychiatric drugs, antidepressant drugs and mania and psychosis, disability from psychiatric drugs, Former pharmeceutical representative speaks out
Older Posts Home
Subscribe to: Posts (Atom)

Pages

  • Home
  • MMJ-Procon
  • MMJ-Norml
  • WeedLegal-Year One
  • Marijuana-a Primer (NORML) PDF
  • Vaporization versus smoking-That is the $60M question....

Blog Archive

  • ▼  2013 (39)
    • ▼  November (6)
      • CANNABIDIOL FOR CHRON'S DISEASE
      • Real World Ramifications of Cannabis Legalization ...
      • Organizations Supporting Immediate Access of Medic...
      • Discussion of Hyperalgesic Effects
      • Cannaboid, Antinociceptive effects, and Neuropathi...
      • Chronic Pain and Medical Marijuana-The Effects on ...
    • ►  October (12)
    • ►  September (3)
    • ►  August (1)
    • ►  July (3)
    • ►  June (1)
    • ►  May (13)

About Me

A. Johnson
View my complete profile

Marijuana as Medicine (Book Display)

Simple theme. Theme images by Roofoo. Powered by Blogger.